Hxcormed

HXCORMED is a Chinese national high-tech enterprise founded in 2016. HXCORMED is dedicated to the research and development of high-end innovative medical devices such as mechanical circulation assist systems. The Corheart 6 Left Ventricular Assist System (the Corheart 6) is a miniaturized magnetic levitation artificial heart that was independently developed by the HXCORMED. The Corheart 6 is an implantable circulatory support system for the treatment of end-stage heart failure. The Corheart 6 is the smallest as well as lightest implantable artificial heart in the world. With a diameter of 34 mm, a thickness of 26 mm, and a weight of 90 g, the blood pump of the Corheart 6 system is 40% smaller in diameter, and 50% lighter compared to existing magnetic levitation artificial heart on the market. The miniaturization design of Corheart 6 makes it applicable to adult and pediatric patients with body surface area larger than 1.2 m2. In July 2023, HXCORMED has gained Chinese NMPA approval for deliver the product into China market. With over 200 patients implanted, follow-up has shown that the Corheart 6 has excellent performance in terms of anti-infection, device reliability, patient recovery, reduced adverse event and improved hemocompatibility. HXCORMED has applied for approximately 200 patents both at home and abroad. Owing to its remarkable strength in R&D, HXCORMED’s innovation achievements in the field of artificial heart is much favored by the capital market. Since 2019, the company has completed three rounds of financing for three consecutive years, and has a steady development momentum.